Holland, MI, United States of America

Carl F Deering


Average Co-Inventor Count = 4.4

ph-index = 8

Forward Citations = 506(Granted Patents)


Location History:

  • Holland, MI (US) (1991 - 1994)
  • Fennville, MI (US) (2001 - 2003)

Company Filing History:


Years Active: 1991-2003

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of Carl F. Deering

Introduction

Carl F. Deering, an accomplished inventor based in Holland, MI, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable nine patents to his name, Deering has focused on creating innovative solutions related to cyclic amino acid compounds. His work provides valuable insights into anticonvulsant therapies, showcasing his dedication to advancing medical science.

Latest Patents

Among his latest inventions, Carl F. Deering has developed an improved process for preparing cyclic amino acid anticonvulsant compounds. This novel synthesis involves treating benzonitrile with an alkali metal and an amine under Birch reduction conditions, which generates an anionic intermediate. This intermediate is subsequently alkylated with an α-haloacetic acid moiety, leading to the production of the desired cyclic amino acid and valuable intermediates utilized in the process. This innovative approach not only enhances the efficiency of the synthesis but also contributes to the potential development of more effective anticonvulsant drugs.

Career Highlights

Deering's career is marked by his dedication to pharmaceutical innovation at Warner-Lambert Company, where he has played a pivotal role in research and development. His commitment to finding unique solutions to complex problems in drug synthesis underlines his status as a leading inventor in his field. With a focus on enhancing therapeutic compounds, his patents reflect a deep understanding of medicinal chemistry and its applications.

Collaborations

Throughout his career, Carl F. Deering has collaborated with notable coworkers, including Donald E. Butler and Alan Millar. These partnerships have fostered a collaborative research environment that stimulates creativity and innovation, ultimately leading to significant advancements in the pharmaceutical domain. Together, they have worked on various projects aimed at improving synthetic processes and product efficacy.

Conclusion

Carl F. Deering’s contributions to the field of pharmaceutical chemistry through his innovative inventions highlight the importance of creativity and collaboration in research. With his extensive portfolio of patents, including the latest synthesis processes for cyclic amino acid anticonvulsants, Deering continues to push the boundaries of what is possible in drug development. His work not only advances therapeutic options for patients but also serves as an inspiration to future inventors in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…